Try it
Pharmacology · Chemotherapy: daptomycin
Sample itemA 62-year-old man with MRSA pneumonia is considered for daptomycin because vancomycin was not tolerated. Why is daptomycin unsuitable?
Original practice item, not a recalled exam question. Nothing here is recorded.
The answer and the reasoning
B. Pulmonary surfactant binds and inactivates it
Daptomycin is a cyclic lipopeptide that inserts into the Gram-positive cell membrane and causes depolarisation. It is useful for MRSA bacteraemia and right-sided endocarditis, but surfactant in the alveoli inactivates it, so it is not used for pneumonia. It can raise creatine kinase, so levels are monitored.
Option by option
A. It is bacteriostatic and cannot kill organisms in lung
It is rapidly bactericidal, not bacteriostatic.
B. Pulmonary surfactant binds and inactivates it (correct)
Correct. Inactivation by surfactant makes it ineffective in pneumonia.
C. It causes severe bronchospasm
Bronchospasm is not a recognised major effect; myopathy is.
D. It lacks activity against MRSA
It is active against MRSA and vancomycin-resistant enterococci.
Source note: Original NextPrep sample item — pending expert review. This item is original practice material awaiting independent expert review, so confirm important facts in a standard textbook.
More Pharmacology questions
- Emergency drugsA patient develops stridor, wheeze and hypotension minutes after an injection. What is t…
- AntiepilepticsWhat is the preferred first-line drug for a patient in generalised convulsive status epi…
- AntimicrobialsWhich drug can cause a disulfiram-like reaction when taken with alcohol?
- AntiepilepticsWhich drug is preferred for uncomplicated childhood absence seizures?